Karen Hunady | Director-Investor Relations & Corporate Communications |
Nancy Simonian | Chief Executive Officer |
David Roth | Chief Medical Officer |
Jason Haas | Chief Financial Officer |
Philip Nadeau | Cowen and Company |
Mark Breidenbach | Oppenheimer |
Jason Butler | JMP Securities |
Good morning, and welcome to Syros Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded.
At this time, I would like to turn the call over to Karen Hunady, Director of Investor Relations and Corporate Communications at Syros.